Welcome to KAHR Medical The mission at KAHR Medical is to develop novel fusion protein
pharmaceuticals for the treatment of cancer and autoimmune
diseases.
The company's drug development pipeline is built around 'signal converter proteins
(SCP)' -
a unique class of multi-functional therapeutic agents that convert signals sent
from one cell to another. Read
More...
Animated clip: SCP technology in autoimmune